Trial Profile
The effects of aripiprazole on patients with 'metabolic syndrome': an open-label trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jan 2008
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Bipolar disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 25 Oct 2006 New trial record.